A Phase II Study of Single Agent Depsipeptide (FK228) (NSC 630176; IND 51,810) in Relapsed Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 11 May 2008 Status changed from in progress to completed.
- 06 Sep 2005 New trial record.